Bioinformatics and biostatistics in epigenetic disease markers and targets

The recent development of high-throughput technologies has led to an explosion of biological data and has enabled mining biomarkers and drug targets in a more systematic way. Bioinformatic and biostatistical approaches are skilled at dealing with large data sets and therefore widely used in mining disease biomarkers and drug targets in this “omic” era.

  • Clinical material
  • ACPA-positive healthy
  • Sampling and DNA extraction
  • DNA preparation and CHARM

Related Conference of Bioinformatics and biostatistics in epigenetic disease markers and targets

February 25-26, 2021

5th Global summit on Cancer Science and Oncology

Vienna, Austria
February 25-26, 2021

20th Global Summit on Breast Cancer

Amsterdam, Netherlands
April 05-06, 2021

2 nd Global Summit on Oncology and Hematology

Berlin, Germany
April 28-29, 2021

11th World Congress on Breast Cancer

Barcelona, Spain
May 17-18, 2021

8th World Congress on Epigenetics and Chromosome

Zurich, Switzerland
May 17-18, 2021

11th World Congress on Breast Cancer & Therapies

Prague, Czech Republic
June 23-24, 2021

41st Euro Congress on Cancer Science & Therapy

Barcelona, Spain
July 12-13, 2021

World Congress on Women Oncology & Care

Melbourne, Australia
July 12-13, 2021

Global Immuno-Oncology & Biomarkers Summit

Melbourne, Australia
July 29-30, 2021

5th Global Summit on Cancer and Oncology Research

Vienna, Austria
August 13-14, 2021

2nd World Cancer, Oncology and Therapeutics Congress

Munich, Germany
August 22-23, 2021

40th World Cancer Conference

Vienna, Austria
September 20-21, 2021

42nd Annual Summit on Oncology and Cancer

Singapore, Singapore
October 07-08, 2021

19th Asia Pacific Oncologists Annual Meeting

London, Aland Islands

Bioinformatics and biostatistics in epigenetic disease markers and targets Conference Speakers

Recommended Sessions

Related Journals

Are you interested in